Skip to content
OpenCapital
Get started

Palvella Therapeutics PVLA Price / sales

Price / sales at other companies

Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
166.6×+109×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
28.2×-3,609×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
1.9×-0.3×
Precigen logo
PrecigenPGEN
102.3×—
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
7×-1.7×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
3.1×-2.7×

Other financials

Income statement

See full
Revenue$53.0K-97.3%
Operating income-$14.9M-88.7%
Net income-$15.8M-92.6%
EPS (diluted)-$1.20-62.2%

Balance sheet

See full
Cash & equivalents$206.4M+173%
Total debt$584.0K—
Total equity$232.3M+318%
Total assets$263.8M+232%

Cash flow

See full
Operating cash flow-$10.9M-60.5%
CapEx--100%
Free cash flow-$2.7M+72.0%

Valuation

See full
Market cap$1.7B+468%
Enterprise value$1.5B—

Profitability

See full
Operating margin-183.2%-13.5pp
Net margin71.7%+40.4pp
FCF margin-99.8%-34.2pp

Returns & leverage

See full
Return on equity-34.2%—
Debt / equity0×—
Current ratio28.9×+20.0×